Suppr超能文献

胃癌根治术后腹膜复发的新型列线图和风险分层。

Novel nomogram and risk stratification for peritoneal recurrence after curative resection in gastric cancer.

机构信息

Department of Medical Oncology, Fujian Medical University Union Hospital, No. 29 Xinquan Street, Fuzhou, 350001, Fujian, China.

Fujian Provincial Key Laboratory of Translational Cancer Medicine, Fuzhou, Fujian, China.

出版信息

Sci Rep. 2024 Aug 17;14(1):19103. doi: 10.1038/s41598-024-70349-y.

Abstract

Peritoneal recurrence (PR) in gastric cancer after curative resection has poor prognosis. Therefore, we aimed to construct a nomogram to predict PR, and establish PR score for risk stratification to guide adjuvant chemotherapy. A total of 315 patients with gastric cancer after radical surgery were included, and randomly stratified into training group (n = 221) and validation group (n = 94). Univariate and multivariate analyses were used to determine predictive factors of PR. The nomogram was constructed to predict the risk of PR. We utilized the time-dependent area under the receiver operating characteristic (ROC) curves (AUCs), calibration curves, and decision curve analysis (DCA) to evaluate the performance of the nomogram. Multivariate analysis showed that tumor site, N stage, preoperative CEA, and postoperative CA199 were independent predictors of PR. A nomogram was constructed to predict PR based on these factors. The AUC value was 0.755 in the training group and 0.715 in the validation group. The calibration curves showed good agreement between prediction and observation in the training and validation groups. The decision curve analysis displayed a good net benefit of the nomogram. The novel PR score was developed and patients were stratified into the low-, medium-, and high -risk groups. For the high-risk group, postoperative adjuvant chemotherapy significantly improved patients' overall survival (OS) and disease-free survival (DFS). The establishment of nomogram facilitates the prediction of PR after radical gastrectomy, and a novel PR score may help guide adjuvant chemotherapy for gastric cancer.

摘要

胃癌根治术后腹膜复发(PR)预后较差。因此,我们旨在构建一个列线图来预测 PR,并建立 PR 评分进行风险分层以指导辅助化疗。共纳入 315 例根治性手术后胃癌患者,随机分为训练组(n=221)和验证组(n=94)。采用单因素和多因素分析确定 PR 的预测因素。构建列线图预测 PR 风险。我们利用时间依赖性接受者操作特征曲线(ROC)下面积(AUC)、校准曲线和决策曲线分析(DCA)来评估列线图的性能。多因素分析显示肿瘤部位、N 分期、术前 CEA 和术后 CA199 是 PR 的独立预测因素。基于这些因素构建了一个预测 PR 的列线图。在训练组和验证组中,AUC 值分别为 0.755 和 0.715。校准曲线显示训练组和验证组的预测与观察结果之间具有良好的一致性。决策曲线分析显示列线图具有良好的净获益。建立了新的 PR 评分,并将患者分为低危、中危和高危组。对于高危组,术后辅助化疗显著改善了患者的总生存期(OS)和无病生存期(DFS)。列线图的建立有助于预测根治性胃手术后的 PR,新的 PR 评分可能有助于指导胃癌的辅助化疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cad/11330521/8fe97ab1a454/41598_2024_70349_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验